Cigna Group $CI Position Reduced by Rhumbline Advisers

Rhumbline Advisers reduced its position in Cigna Group (NYSE:CI) by 3.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 555,555 shares of the health services provider’s stock after selling 18,668 shares during the period. Rhumbline Advisers’ holdings in Cigna Group were worth $160,139,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Brighton Jones LLC grew its holdings in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares in the last quarter. Sivia Capital Partners LLC boosted its position in Cigna Group by 10.4% during the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after acquiring an additional 109 shares during the period. Concurrent Investment Advisors LLC increased its holdings in shares of Cigna Group by 1.6% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 5,068 shares of the health services provider’s stock valued at $1,675,000 after purchasing an additional 81 shares during the period. Sequoia Financial Advisors LLC lifted its position in shares of Cigna Group by 19.5% in the second quarter. Sequoia Financial Advisors LLC now owns 7,740 shares of the health services provider’s stock worth $2,559,000 after purchasing an additional 1,265 shares in the last quarter. Finally, Verdence Capital Advisors LLC boosted its holdings in shares of Cigna Group by 32.0% during the second quarter. Verdence Capital Advisors LLC now owns 3,046 shares of the health services provider’s stock worth $1,007,000 after purchasing an additional 739 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on CI. The Goldman Sachs Group reduced their price objective on Cigna Group from $370.00 to $330.00 and set a “buy” rating for the company in a research report on Tuesday, November 4th. Guggenheim restated a “buy” rating and set a $318.00 target price on shares of Cigna Group in a report on Monday, February 2nd. UBS Group reiterated a “buy” rating and set a $375.00 price target on shares of Cigna Group in a research note on Monday. Leerink Partners raised their price objective on Cigna Group from $270.00 to $297.00 and gave the company a “market perform” rating in a research note on Friday, February 6th. Finally, JPMorgan Chase & Co. decreased their target price on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday, November 4th. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $330.00.

Cigna Group Price Performance

Shares of Cigna Group stock opened at $294.27 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.74 and a quick ratio of 0.76. The company has a market cap of $78.61 billion, a PE ratio of 13.27, a price-to-earnings-growth ratio of 1.00 and a beta of 0.27. The firm has a fifty day moving average price of $275.93 and a two-hundred day moving average price of $283.71. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00.

Cigna Group (NYSE:CI) last announced its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the prior year, the business earned $6.64 earnings per share. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Thursday, March 5th will be paid a $1.56 dividend. The ex-dividend date is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group’s dividend payout ratio is currently 27.23%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.